Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mick,
Your summary of recent VRCI announcements is something people should keep in mind. The company has previously assembled a world-class R&D team capable of making significant strides in the treatment of numerous medical conditions. Now they have built a Board and Financial team that seems very able to raise the funds necessary to execute on its R&D program. Verde is poised to move forward and deliver huge gains.
I wonder if the market understands the significance of these alliance partners. Premier organizations ready to start Verde's R&D programs. India has more experience with MMJ research over a longer period of time than any other place in the world!
Up 50% in last few days. Something is going to be announced soon, IMO. Spinout and Uplisting? Financing? Takeoff Agreement? Something is brewing.
That is a great find Mrgoodtrade. Immudyne has world class products with proven efficacy and now there is another important indication. Why can't the marketing challenged CEO, self-dealing Mark McLaughlin leverage off of the potency of the products and launch the company into major chains? He has had 5 or 6 years to do so. He is a marketing novice. He blew over half a million dollars with 2 poor decisions on marketing people -- Karen Kingston who sold him a bill of goods on her plan to use social media and John Burke, who convinced the marketing challenged MCLaughlin that he could bring in wholesale business. Now after he burned up $550,000 in misspent marketing dollars and raising his salary 45% since 2011, the company seems unable to find the resources to bring on 1 or 2 larger distributors who can get IMMD into the chains, and unable to conclude any blockbuster deals with large players in the alternative health sector. See, it is a 'guns and butter' issue at this point IMMD doesn't have $$ for important marketing measures because the self-dealing McLaughlin extracts way too much cash paying himself and his wife excessive salaries. And all the while the stock price languishes at $.09 because IMMD doesn't have the spare cash to conduct financial p.r. to bring new investors to IMMD.
Lane Deyoe, NO I have not sold any shares at all this year. I am not slamming McLaughlin's management and excessive compensation in an effort to hurt the company. My goal is to effect change in IMMD, so that all shareholders can benefit from effective management of IMMD's marketing process.
Look at the facts: The stock is at $.09, down 70% from January 2011. McLaughlin's salary is up 45%, from $100,000 to $145,000 during the same period. Your investment is down more than 50% in a year! Self-dealing CEO McLaughlin also awarded himself millions of options and even awarded his wife who does p-t bookkeeping for the company, 200,000 options, as he made a devastating mistake on Karen Kingston that burned $350,000 and yielded NO sales.
No wonder the stock sells at $.09 today when there are no announcements on marketing engagements with large distributors who can get IMMD's products into large chains, there are no pr's detailing IMMD's participation at major neutraceutical conventions, such as the World Neutraceutical Conference in Philadelphia in July or Supply Side West, and there is no financial public relations program that will bring new investors to IMMD, when McLaughlin is extracting so much cash and there is no cash for such important marketing and pr tactics.
EVERY SHAREHOLDER SHOULD BE EMAILING AND CALLING MClAUGHLIN AND HIS RUBBER STAMP CHAIRMAN ANTHONY BRUZZESE AND DEMANDING THAT MCLAUGHLIN'S SALARY BE CUT IN HALF, HIS OPTIONS BE SEVERELY REDUCED, AND AN OBJECTIVE COMPENSATION COMMITTEE BE APPOINTED, SO THAT MONEY CAN BE DEVOTED TO IMPORTANT MARKETING MEASURES THAT WILL GET IMMD MOVING!
Interesting information from Immudyne’s report filings:
From the Annual OTCQB Certification paragraph f.:
Name Address (City and State only) % Shares Owned
Lane Deyoe, M.D.
11997 N. Lake Dr. Boynton Beach, FL 33436 7.4
From the Immudyne 10 K:
Private Placements
In 2013, we issued 500,000 shares of our common stock (and three-year warrants to purchase 250,000 shares) of our common stock at $0.40 per share to accredited investors at $0.25 per unit for $125,000 in gross proceeds.
Wow XRYMD, looks like the value of your investment is down more than 50%, so I understand your reflexive action in defending a self dealing CEO who does not seem to be able to market a world-class product with proven efficacy. However, that will not improve things for Immudyne. Immudyne needs fundamental change. All IMMD shareholders should stop ignoring the obvious. Why hasn’t McLaughlin been able to ramp up sales of a break-through product? Why hasn’t he executed an agreement with a substantial nutriceutical/pharmaceutical distribution firm to get IMMD’s products into the major chains? Why instead did he burn $350,000 with Karen Kingston to market through social media, and $200,000 with John Burke to sell to wholesale users, both yielding NO sales? Obviously, because he does not understand marketing.
We need a change. McLaughlin’s salary should be cut in half, his options should be severely reduced, an objective compensation committee should be appointed by the Board, and the savings in salary and options should be used to hire an experienced industry distribution consultant to get it done!
Pretty typical response from someone who is trying to defend a self-dealing CEO who enriches himself while the company under-performs. You attempt to deflect the criticism with irrelevant responses that have nothing to do with IMMD's under-performance and McLaughlin's marketing incompetence. What the CEO of another company does has absolutely nothing to do with me ow with the IMMD situation. I don not set corporate policy, I only write press releases and take investor and shareholder calls. I am aware that McLaughlin put you up to this, because I know he has asked people about me and my involvement with another company. You are trying to defend the indefensible with smoke and disparaging another CEO and company that have nothing to do with the self-dealing and under-performance at IMMD. Shows your level of integrity. Carrying water for a self-dealer.
Here is the bottom line which you cannot defend with more obfuscating twaddle -- since January 2011 the IMMD stock price has declined 60%, while self-dealing McLaughlin raised his salary by 45% and awarded himself millions of options. IMMD has a world-class, proven product. McLaughlin has demonstrated that he is incompetent in marketing that product. He has not earned his compensation package. This is undisputable. When you blow smoke in order to deflect the criticism you only underscore the truth of what I say and diminish your image in the eyes of others.
Let's try to raise the level of discussion. I will be happy to compliment McLaughlin if a surge in sales occurs and the stock price soars. It will benefit me and all other shareholders. However, my criticism will still be correct. He raised his salary over the last 5 years while the company and shareholders lost money. That is wrong and will always be wrong. He should cut his salary, rollback his options remove his wife's options and appoint an objective compensation committee. Then he could spend more on marketing and sales and grow IMMD.
You want to snuff free speech? The company has been mismanaged by McLaughlin and I have MORE right to state my case than you do to defend that failure. I have been a shareholder for nearly 8 years. I am the fifth largest shareholder of Immudyne. I have put my money where my mouth is. When McLaughlin was in a fund raising mode in the past, at his behest I placed supporting bids to keep the stock price up. I assisted in the writing of press releases with no compensation. I helped the company in the past and I am helping the company now by exposing McLaughlin's incompetence so that changes may be made. IMMD has a world-class product with proven efficacy. But McLaughlin cannot market nearly as well as he can reward himself with excessive salaries and award himself and his wife excessive options. His decisions on people to do the marketing have also been atrocious -- Karen Kingston (cost $350,000) and another bozo before her that cost $200,000) both with no results.
Check the latest Q filing. He had to borrow $100,000 because he pays himself $145,000 and his wife $24,000. How is that justified when the company was losing money? Maybe the first Q was B-E, but for a company with the most superior product in the space and with 6 years to get it going that performance deserves failing grades.
In Jan., 2011 the stock price was $30. It is now $12. Are you really satisfied with McLaughlin's performance? This is the issue!
Don't tell me to move along. Keep up trying to keep me quiet and I will reveal much more!
This company has gone nowhere in the last 5 years. McLaughlin just promises, brings in new personnel who he overpays -- remember Karen Kingston the marketing guru who burned up $350,000 in salary and expenses and brought on NO biz? Remember the promises after that Mclaughlin made about radio advertising, internet advertising, remember Quizzo? Mclaughlin ia a joke. He has burned up close to half a million in failed marketing expenses and the shareholders have suffered! Remember when the stock was at $.30 and showed all kinds of promise? McLaughlin's failed leadership has hurt IMMD and the shareholders. Yet he makes $145,000 per year, has awarded himself 9 million options, even pays his wife $24,000 per year to be a p-t bookkeeper and even awarded her 200,000 optionS (for a p-t bookkeeper?) While the company loses money! This failed leadership is sickening. I objected in several emails to McLaughlin AND Bruzzese (the chair) and was basically told to pound sand! When I requested a shareholder list so I could mount an effort to have things changed, I received an email from John Strawn, Esq, a member of the board saying that I was out of line in my request.
EVERY SHAREHOLDER SHOULD INUNDATE MCLAUGHLIN, AND BRUZZESE WITH DEMANDS THAT COMPENSATION BE LOWERED IMMEDIATELY AND THAT A NON-BOARD COMPENSATION COMMITTE BE APPOINTED. STOP THE SCUMBAHS FROM RAPING THE SHAREHOLDERS!!!!!!!!!! Don't let the rapists get away with it!!!!
I checked out the Hellawella article and it is spectacular. Not exaggerating. States the case for IMMD's products and their superiority in a very convincing manner. Also checked out the author, Dr. Stephen Petterutti. Second generation physician who runs the Petterutti Center for Life Extension. Though he is board certified Doc, he focusses on alternative medical treatments for cancer, degenerative diseases and anti-aging. If this guy is a proponent of IMMD's products it is significant. His endorsements plus the Sedona Clinic, which will hopefully begin the inflammations study soon wil help IMMD soar above its competition. Going to dollar land this year!
Whatever it is, something substantial is about to happen or be announced. Fifty-four million is 12 times the 10 day ave. daily volume and the day is not over. Even at these low prices it amounts to $32,000, not an insubstantial amount of money. I believe that the issue holding up the financials has been overcome and that has allowed the a/r lender to move to approve the line. Note that there is nothing for sale at this level any more.
So much trash talk w/o any substance. Yes, the s/p has declined a lot. Yes financials are late and we have not received any recent updates. But, the many ad hominem comments by 3 or 4 posters mounting to scores per poster in just the first 3 weeks of the year lead me to belive that these 3 or 4 people have a personal vendetta against Barry Schwartz. The benfit of an ihub board is for traders and investors to share relevant info and DD. These nasty posts just stink up the board. I did some DD in the last few days. I spoke with retailers who carry pet foods. I spoke with several people connected with the company (and they are always available and as forthcoming as possible.) I spoke with users of the products. Bottom line: the company IS NOT DEAD! People love the products. Pet food retailers are looking for new products, especially dog food products manufactured in the U.S. The recent China scares have retailers salivating to try new treats and meals. Walmart loves AAPT. The comapny will release financials very soon and the hold up will be seen to be for a very good reason. Company had numerous opportunities for new orders with existing and new outlets. Putting final touches on a/r credit line to enable new shipments. Credit line awaiting release of financials. All good. Very soon now. Resist the attempt of a few with a personal vendetta to make long-term investors depressed.
Talk to Dan. He is very accessible and will say as much as he can w/o violating. The SOE deal is NOT dead. They are still interested and the NI report will help their confidence level. They are just 1 of many who have expressed interest in teaming up with SRSR in some fashion after the report is complete.
I am so pleased that company has made this move. This is the MOST effective marketing tool for nutriceuticals, bar none! I have participated in this market off and on for years and I have seen what sells and where. IMMD has the most important and critical aspect going for it -- THEIR PRODUCTS WORK! They just need an effective communication method to attract new customers and radio advertising on health and wellness programs are very effective.
I just reordered and decided to change my product to the fitness product with twice the beta glucan -- 15 mg. Though the basic product has always worked for me (7.5 mg.) and I have not been sick in the 7 years since I started, this high potency formulation actually provides an almost immediate feeling of euphoria followed by an energy surge. Must be the intense chemical reaction at the cellular level. Take advantage of the 3 pack discount and it makes it really worth the small extrat cost. I have been able to step up my workouts and I am not drained after an intense one.
That Kingstom woman was a waste. Total fraud. Social media fails with nutriceuticals because there is no opportunity to offer full explanation of products and their results. Could possibly be effective with a hangover remedy when IMMD does studies and launches the product because all that has to be said is it works for relief of hangovers and many people especially younger will try it.
Finally, just wait for the results of the Sedona Clinic study on beta glucan's effect on inflamation. Most likely will be a game changer since Sedona Clinic is considered a REAL SOURCE by health and wellness gurus. It is my understanding that researchers already know that their is a positive effect at the cellular level on inflammation. It just needs to be verified by the study. THIS WILL BE BIG!
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
Sangha Harpreet Singh 2. Issuer Name and Ticker or Trading Symbol
VERDE SCIENCE, INC. [ VRCI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director _____ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
CEO
(Last) (First) (Middle)
#45-6671 121 STREET 3. Date of Earliest Transaction (MM/DD/YYYY)
9/30/2014
(Street)
SURREY, A1 V3W 1T9
(City) (State) (Zip) 4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 9/30/2014 P 1000000 A $0.012 11000000 D
Common Stock 9/30/2014 P 1000000 A $0.0122 12000000 D
$24,000 worth at $.012. It ain't chicken feed. and is at much higher price. If he is buying we should certainly be thinking about adding here!
IMMD's patented processes for the extraction of the beta glucan molecule from baker's yeast produces a formulation that is many times more pure than any beta glucan on the market. If you read the research on IMMD's website it will demonstrate why the most pure form of beta glucan is critical to the efficacy of the product. Basically, the impurities in IMMD's competitior's products "clog up" the receptors at the cellular level so the beta glucan never makes it into the cells and is therefore ineffective. That is why the dosage for IMMD's products is 7.5 mcg to 15 mcg, while the competitior's measures in the mg's. Their products are loaded with impurities (carbohydrates, incipid proteins, etc.)
Efficacy is the key. IMMD's products work. The other's don't.
The scientists are all professors at a prestigious university that is also an alliance partner with capabilies for conducting research. The allied pharmaceutical company is a bricks and mortar company with its own R&D facility. Should Verde spend $$ needlessly to duplicate what already exists? I think the synergy and low-cost and nimble structure of Verde's operating philosophy is what makes it so compelling. I think they are also working on an alliance(s) in Canada and that may be why Harp brought in the Chief Technology Officer. Like I said in previous post, they are in a building and growth mode and IMO they are doing it the right way.
I must have struck a chord with my post, because you immediately posted 3 negative posts with additional bogus statements. However none of them addressed my post that your accusation about Harp selling shares was ridiculous, since the cash provided with the price at these levels was not significant. Anyone who posts 5 to 10 negative posts per day IS a basher with an ulterior motive. One thing you are right about is that you should be ignored.
Regarding your statements that the company was pumping with the intention of selling shares, you are again ridiculous and are attempting to create a negative view of Harp and Verde. I wonder why? There were no posts that I saw that spoke of either specific content or a specific day for any announcement. Verde is in a building and growth mode. Harp is bringing in researchers, pharmaceutical firms, prestigious universities, and a new CTO to accoomplish the R&D on the company's projects. With this flurry of recent activity going on, any poster who is exuberant about Verde and its growth prospects could predict that info is coming out and probably appear to be right within a week.
Harp is building an impressive platform. Execution will follow and so will the s/p.
What a ridiculous post. A million shares yields $5,000 No way Harp or the company can generate any meaningful cash that way. You have been a basher since day one. Thoughful people here should simply ignore you.
The company is building a premier R&D platform. Execution will trump silly rumor creation, by people with an ulterior motive, and reward long-term holders. This company is participating in the Medical Marijuana sector the right way-- actually isolating and producing medically beneficial preparations. The growers and marketers of smoking dope will have limited markets, high costs and intense competition. Most will not be around in 2 years.
Ditto. Verde is moving forward on the execution of it plan. The new CTO was obviously added to execute on their plan, which IMO is the most astute plan in the space. Verde would not commit the funds for this obviously experienced executive without having lots for him to do. Eventually the fundamentals and plan execution will trump the short sellers and their consistantly negative posts on this board.
Verde just posted an Investor Summary on their website. Impressive vision and plan IMO. Click on link on their home page.
Former successful hedgefund manager. Investor. Public company builder. Happy to have him aboard.
This is just what is needed. Kudos to Scott for having the courage and being introspective enough to ask for help in getting SRSR to the next stage. He is a good geologist who keyed in on the mineral and got control of the field, but perhaps not the guy the company needs right now to move it forward. I know Dan Byrnes and he is the one to do what is needed to prove the claim, get new eyeballs on SRSR, raise the necessary capital and get the s/h's value. Dan gets things done. "Pity the fool" who delays Dan's plan achievement!